El-Saiedi Sonia A, El Sisi Amal M, Mandour Rodina Sobhy, Abdel-Aziz Doaa M, Attia Wael A
Department of Pediatrics, Division of Pediatric Cardiology, Cairo University Children's Hospital, Cairo, Egypt.
Ann Pediatr Cardiol. 2017 May-Aug;10(2):144-151. doi: 10.4103/0974-2069.205138.
In this study, we examined the differences in cost and effectiveness of various devices used for the closure of small to medium sized patent ductus arteriosus (PDA).
We retrospectively studied 116 patients who underwent closure of small PDAs between January 2010 and January 2015.
Three types of devices were used: the Amplatzer duct occluder (ADO) II, the cook detachable coil and the Nit Occlud coil (NOC). Immediate and late complications were recorded and patients were followed up for 3 months after the procedure.
All statistical calculations were performed using Statistical Package for the Social Science software. <0.05 were considered significant.
We successfully deployed ADO II devices in 33 out of 35 cases, cook detachable coils in 36 out of 40 cases and NOCs in 38 out of 41 cases. In the remaining nine cases, the first device was unsuitable or embolized and required retrieval and replacement with another device. Eleven patients (9.5%) developed vascular complications and required anticoagulation therapy. Patients who had hemolysis or vascular complications remained longer in the intensive care unit, with consequently higher total cost ( = 0.016). Also, the need for a second device increased the cost per patient.
The cook detachable coil is the most cost-effective device for closure of small-to medium-sized PDAs. Calculations of the incremental cost-effectiveness. (ICE) revealed that the Cook detachable coil had less ICE than the ADO II and NOC. The NOC was more effective with fewer complications.
在本研究中,我们考察了用于闭合中小尺寸动脉导管未闭(PDA)的各种装置在成本和有效性方面的差异。
我们回顾性研究了2010年1月至2015年1月期间接受小型PDA闭合术的116例患者。
使用了三种类型的装置:Amplatzer动脉导管封堵器(ADO)II型、库克可分离线圈和Nit Occlud线圈(NOC)。记录即时和晚期并发症,并在术后对患者进行3个月的随访。
所有统计计算均使用社会科学统计软件包进行。P<0.05被认为具有统计学意义。
我们在35例中的33例成功部署了ADO II型装置,40例中的36例成功部署了库克可分离线圈,41例中的38例成功部署了NOC。在其余9例中,第一种装置不合适或发生栓塞,需要取出并更换为另一种装置。11例患者(9.5%)出现血管并发症,需要抗凝治疗。发生溶血或血管并发症的患者在重症监护病房停留的时间更长,因此总成本更高(P = 0.016)。此外,需要使用第二种装置增加了每位患者的成本。
库克可分离线圈是闭合中小尺寸PDA最具成本效益的装置。增量成本效益计算(ICE)显示,库克可分离线圈的ICE低于ADO II型和NOC。NOC更有效,并发症更少。